Cambridge Cognition Holdings PLC Director/PDMR Share Purchases
28 December 2024 - 2:34AM
RNS Regulatory News
RNS Number : 4875R
Cambridge Cognition Holdings PLC
27 December 2024
27 December 2024
Cambridge Cognition Holdings
Plc
("Cambridge Cognition", the "Company" or the
"Group")
Director/PDMR Share
Purchases
Cambridge Cognition Holdings Plc
(AIM: COG), which develops and markets digital solutions to assess
brain health, was informed on 24 December
2024 that Debra Leeves, Non-Executive Director of the Company,
purchased 28,750 ordinary shares of 0.01 pence each ("Ordinary
Shares") in the Company at a price of 34.44 pence per
share.
Following this transaction, Debra
Leeves holds an interest in 113,750 Ordinary Shares, representing
approximately 0.27% of the Company's issued share
capital.
Further information on the purchases
is contained in the disclosure tables below.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM:
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Debra Leeves
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Non-Executive Director
|
|
b)
|
Initial notification
/Amendment
|
Initial notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Cambridge Cognition Holdings
Plc
|
|
b)
|
LEI
|
213800SZKDIN122EPA96
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument
Identification code
|
Ordinary shares of 0.01p
each
GB00B8DV9647
|
|
b)
|
Nature of the transaction
|
Purchase of Shares
|
|
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
34.44 pence
|
28,750
|
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A
|
|
e)
|
Date of the transaction
|
24 December 2024
|
|
f)
|
Place of the transaction
|
London Stock Exchange
|
Enquiries:
|
Cambridge Cognition Holdings
plc
Dr Steven Powell,
Chairman
|
Tel: 012 2381
0700
|
|
Hudson Sandler (Financial PR and
IR)
Dan de Belder / Hattie Dreyfus /
Harry Griffiths
|
Tel: 020 7796
4133
cog@hudsonsandler.com
|
|
Panmure Liberum Limited (NOMAD and
Joint Broker)
Will Goode / Freddy Crossley / Mark
Rogers
Rupert Dearden
|
Tel: 020 7886
2968
(Corporate
Finance)
(Corporate
Broking)
|
|
Dowgate Capital Limited (Joint
Broker)
David Poutney / James
Serjeant
|
Tel: 020 3903
7715
|
|
Notes to
Editors
About
Cambridge Cognition
Cambridge Cognition is a leading
technology company specializing in digital health products that
advance brain health research and treatment. The Company offers
three core products: CANTAB® assessments, which provide
scientifically validated, highly sensitive, precise, and objective
measures of cognitive function correlated to neural networks; a
flexible and proven eCOA platform, with a large library of
instruments, enabling efficient study set up and scalable data
capture; and Quality Assurance Tools that ensure data integrity by
automatically detecting deviations in administration and scoring,
saving time and money. Together, these products improve clinical
trial outcomes, enable early patient identification, and enhance
global efficiency in healthcare and pharmaceuticals.
For further information
visit: https://cambridgecognition.com/
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
DSHPPGWWPUPCGAM
Cambridge Cognition (LSE:COG)
Historical Stock Chart
From Dec 2024 to Jan 2025
Cambridge Cognition (LSE:COG)
Historical Stock Chart
From Jan 2024 to Jan 2025
